CB PHARMA ACQUISISTION CORP SHS (CYM)
CNLM
CNLM was delisted on the 8th of June, 2016.
8 hedge funds and large institutions have $18.4M invested in CB PHARMA ACQUISISTION CORP SHS (CYM) in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
24% more capital invested
Capital invested by funds: $14.8M → $18.4M (+$3.52M)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
11% less funds holding
Funds holding: 9 → 8 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DKCM
Davidson Kempner Capital Management
New York
|
+$3.5M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
-$224K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$12K |
| 3 |
Morgan Stanley
New York
|
-$10 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAMP
1
Polar Asset Management Partners
Toronto,
Ontario, Canada
| $5.55M | – | – | – |
|
|
WAM
2
Weiss Asset Management
Boston,
Massachusetts
| $4.28M | – | – | – |
|
|
AA
3
AQR Arbitrage
Greenwich,
Connecticut
| $3.54M | – | – | – |
|
|
DKCM
4
Davidson Kempner Capital Management
New York
| $3.54M | +$3.5M | +350,000 | New |
|
|
KIM
5
Karpus Investment Management
Pittsford,
New York
| $1.33M | – | – | – |
|
|
YCM
6
Yakira Capital Management
Westport,
Connecticut
| $126K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $3K | +$1K | +100 | +49% |
|
|
GCL
8
Glazer Capital LLC
New York
| – | -$224K | -21,824 | Closed |
|
|
9
UBS Group
Zurich,
Switzerland
| – | -$12K | -1,233 | Closed |
|
|
10
Morgan Stanley
New York
| – | -$10 | -1 | -10% |
|
CNLM Hedge Fund Activity: Q1 2016 in Review
8 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) for Q1 2016, worth a combined $18.4M — up 24% from $14.8M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CNLM and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Davidson Kempner Capital Management, opening a new position worth an estimated $3.5M. The largest seller was Glazer Capital LLC, exiting entirely with an estimated $224K sold.
- 8 institutional investors held CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) as of Q1 2016, down from 9 in Q4 2015.
- Funds reported $18.4M of CB PHARMA ACQUISISTION CORP SHS (CYM) stock for Q1 2016, up 24% quarter-over-quarter.
- 1 fund opened new CB PHARMA ACQUISISTION CORP SHS (CYM) positions in Q1 2016 and 2 closed out, a net change of -1 holder.
- The largest CB PHARMA ACQUISISTION CORP SHS (CYM) buyer in Q1 2016 was Davidson Kempner Capital Management, an estimated $3.5M added.
- The largest CB PHARMA ACQUISISTION CORP SHS (CYM) seller in Q1 2016 was Glazer Capital LLC, an estimated $224K sold.
Based on aggregated 13F filings for Q1 2016.